205 results on '"G. Sorce"'
Search Results
2. Recovery from transient urinary incontinence post-HoLEP – findings from a prospective trial (EXPHO)
3. Prognostic value of high PIRADS score lesions at mp-MRI of the prostate in men with low risk prostate cancer managed with active surveillance. results from a single institution series
4. A positive PSMA PET/CT Predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy
5. The impact of persistently elevated PSA levels on progression and survival of patients undergoing cytoreductive radical prostatectomy for oligometastatic prostate cancer
6. The relative drop of PSA values after androgen deprivation therapy is a useful parameter to select the best candidate for cytoreductive radical prostatectomy among patients with oligometastatic prostate cancer: an external validation study
7. Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: results from the national cancer database
8. Is focal ablation as effective as hemi-ablation? Analysis of treatment patterns over 12 years from a high volume centre for focal therapy
9. The relationship between percentage PSA reduction and rate of failure after focal therapy for prostate cancer
10. A positive PSMA PET/CT predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy
11. The Undiscovered Ultradiffuse Galaxies of the Local Group
12. The Baryonic Tully-Fisher Relation cares about the Galaxy Sample
13. The hestia project: simulations of the Local Group
14. Scattering of Lyα Photons through the Reionizing Intergalactic Medium: I. Spectral Energy Distribution
15. Hermeian haloes: Field haloes that interacted with both the Milky Way and M31
16. The undiscovered ultra-diffuse galaxies of the Local Group
17. Exploring the effect of metastasis directed therapy on progression patterns of patients with positive 68Ga-PSMA PET/CT and biochemical recurrence from prostate cancer
18. Is there an impact of the center performing baseline multiparametric MRI on active surveillance outcomes in prostate cancer patients?
19. Identifying the optimal candidates for concomitant androgen-deprivation therapy among patients receiving metastasis-directed therapy for positive 68Ga-PSMA PET/CT for biochemical recurrent prostate cancer after radical prostatectomy
20. Impact of radiologist expertise on PI-RADS distribution and detection of clinically significant prostate cancer: Results from a single, high volume center
21. When is central histological review of prostate biopsy really needed to reduce the risk of misclassification of prostate cancer? The importance of patient risk stratification
22. Can we predict the site of positive surgical margins based on the site of the index lesion at multiparametric mri? A topographic, single center study
23. Anisotropic satellite accretion onto the Local Group with HESTIA
24. Reionization time of the Local Group and Local-Group-like halo pairs
25. Not all adverse pathology features are equal: identifying optimal candidates for adjuvant radiotherapy among patients with adverse pathology at radical prostatectomy
26. Reliability of 68Ga-PSMA PET/CT in assessing real nodal burden in men with cN1 disease: clinical implications for patient counselling and multi-modal treatments
27. The risk of recurrence in cN1 prostate cancer patients treated with radical prostatectomy varies according to the type preoperative staging. a comparison between 68ga-PSMA-PET versus conventional imaging in a large, multi-institutional study
28. The past history of galaxy clusters told by their present neighbours
29. The short ionizing photon mean free path at z=6 in Cosmic Dawn III, a new fully-coupled radiation-hydrodynamical simulation of the Epoch of Reionization
30. Cold and Hot gas distribution around the Milky-Way-M31 system in the HESTIA simulations
31. Kinematics of the Local Group gas and galaxies in the Hestia simulations
32. Impact of Prostate Imaging Quality (PI-QUAL) score on the detection of clinically significant prostate cancer in men undergoing MRI-targeted biopsy
33. Defining the optimal target-to-background count rate to identify positive lymph nodes in patients undergoing robot-assisted 99mtc-PSMA-radioguided surgery for prostate cancer: A per-region analysis of a prospective, phase II study
34. Tailoring the optimal use of androgen-deprivation therapy concomitant to post-operative radiotherapy among men with pN1 prostate cancer. Long-term results of a large, single Institution series
35. A novel model Integrating clinical, mp-MRI, and epigenomic features to predict lymph node invasion in prostate cancer patients undergoing radical prostatectomy and pelvic lymph node dissection
36. Management of atypical recurrence after treatment of localized renal cell carcinoma: Retrograde intrarenal surgery as an option
37. Effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy
38. A more extended pelvic lymph node dissection decreases recurrence rates in selected prostate cancer patients undergoing radical prostatectomy
39. Effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy
40. A timely administration of metastasis-directed therapy can reduce the risk of disease progression in men with positive 68Ga-PSMA PET/CT for biochemical recurrence after radical prostatectomy
41. Detection of clinically significant prostate cancer in mpMRI visible lesions: size matters. Results from a large, two-institutional series
42. Impact of 68Ga-PSMA PET/CT and metastasis-directed therapy on clinical recurrence in patients with biochemical recurrence after radical prostatectomy. results from a single center series
43. Has the introduction of mpMRI in the diagnostic pathway of prostate cancer led to improved oncological outcomes after radical prostatectomy? Result from a large single-institutional series
44. The impact of histological variants on the performance characteristics of 68Ga-PSMA PET/CT in the primary and recurrent setting
45. The association of type and number of d’amico high-risk criteria with rates of pathologically non organ confined prostate cancer
46. Does previous prostatic surgery affect the accuracy of multiparametric MRI in detecting clinically significant prostate cancer? Results from a single center, high volume series
47. Survival after radical prostatectomy vs. radiation therapy in clinical node-positive prostate cancer
48. NIHAO-LG: The uniqueness of Local Group dwarf galaxies
49. Drop-out rates from active surveillance for disease progression remain consistent and not negligible over time. A plea for long-term assessment based on a large, prospectively collected active surveillance cohort
50. Detection of clinically significant prostate cancer in mpMRI visible lesions: Size matters. Results from a large, two-institutional series
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.